Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1932.71 (Glytoucan)

Id:20afa5b7-5776-596a-9c57-e69842718339

Glytoucan:G32165MO

Results found

Linked to

	Label	Description
	1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000139 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G66278QZ-GLYCOSEQ00001695 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G81085EP-GLYCOSEQ00022151 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G25407RZ-GLYCOSEQ00113578 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has motif Blood group A1 (type 3) Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G37291PT-GLYCOSEQ00139403 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G73683LQ-GLYCOSEQ00119360 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000151 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G10627KR-GLYCOSEQ00175143 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000128 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000139 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G66278QZ-GLYCOSEQ00001695 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G81085EP-GLYCOSEQ00022151 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G25407RZ-GLYCOSEQ00113578 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has motif Blood group A1 (type 3)

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G37291PT-GLYCOSEQ00139403 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G73683LQ-GLYCOSEQ00119360 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000151 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1932.71 has glycosequence GLYGEN.GLYCOSEQUENCE:G10627KR-GLYCOSEQ00175143 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.